International law firms in Japan might have taken a big hit over the past two years when their Japanese clients, cowed by COVID, put outbound M&A deals on hold and plunged Japan’s outbound M&A activity to its lowest level in 20 years.
Instead, many of those firms shifted gears along with their clients. And even as COVID fears subside, this change has given them new avenues for growth.
While outbound M&A work—the bread and butter of many international firms—dried up, law firms seized on opportunities that arose with an uptick in inbound investments by private equity firms and tech companies, with the divestiture of non-core assets by Japanese corporates, and with an increase in cross-border antitrust filings. For many, the silver lining of COVID has been a broadening of their offerings in Japan.
Firms such as Herbert Smith Freehills, Skadden, Arps, Slate, Meagher & Flom and K&L Gates, which built up practices in Tokyo advising Japanese companies on outbound M&A transactions, saw their Japanese clients suspend their overseas M&A plans—hesitant to pursue them because Japanese corporates generally prefer to do face-to-face meetings and onsite due diligence—activities that have been almost impossible over the past two years.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI